Agilent SLIMS
Pharma Focus Asia
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

22

Oct 2021

Oncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates

Oncodesign a French biopharmaceutical company specialized in kinase inhibitor research and precision medicine and TiumBio a company specializing in RD for rare diseases have announced the signature of a research collaboration agreement on RD of potential drug candidates for fibrosis Under this agree...

22

Oct 2021

Mablink Bioscience and Emergence Therapeutics Enter Into a Licensing Agreement to Develop Antibody Drug Conjugate as a Potential Cancer Therapy

Mablink Bioscience SAS a biotechnology company developing a pipeline of ADC based on its proprietary PSARlink druglinker technology and Emergence Therapeutics AG a European biopharmaceutical company developing novel antibody drug conjugate ADC immunotherapeutics to treat cancers with high unmet need...

21

Oct 2021

Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.

Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines today announced that the US Food and Drug Administration FDA has authorized for emergency use a booster dose of the Moderna COVID vaccine mRNA at the g dose level for people aged and older people aged to...

21

Oct 2021

Biotage acquires ATDBio and strengthens its position in DNA and RNA Oligonucleotide synthesis and purification

Biotage AB has entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited ATDBio based in Oxford and Southampton UK for a total purchase price of approx MGBP on a debt free and cash free basis corresponding to approx MSEK financed through a combination...

20

Oct 2021

FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH

FSD Pharma Inc a life sciences holding company dedicated to building a portfolio of assets and biotech solutions announced today it has entered into an agreement with Covar Pharmaceuticals Inc Covar a contract development and manufacturing services organization CDMO to commence work on providing res...

20

Oct 2021

CDISC and OpenClinica Collaborate to Drive Academic Clinical Research Forward

CDISC announced that it is collaborating with OpenClinica to improve data collection in clinical studies conducted by academic institutions and researchers with the goal of driving research forward The collaboration came about as a result of CDISCs efforts to better understand the barriers among the...

press releasesRead more...

21

Oct 2021

Ferrer and Treeway enter into licence agreement for the development and commercialisation of TW001/FNP122 for Amyotrophic Lateral Sclerosis

Ferrer an international pharmaceutical company focused on pulmonary vascular and interstitial lung diseases and neurological disorders and Treeway a clinicalstage biotechnology company announced they have entered into a licence agreement for the development and commercialisation of an oral formulati...

21

Oct 2021

Antengene Enters into a Research Collaboration & License Option Agreement with LegoChem Biosciences for New Antibody-Drug Conjugate Candidates

Antengene Corporation Limited a leading innovative biopharmaceutical company dedicated to discovering developing and commercializing global firstinclass andor bestinclass therapeutics in hematology and oncology today announced that it has entered into a Research Collaboration and License Option Agre...

21

Oct 2021

Atreca Enters into Licensing Agreement with Bill & Melinda Gates Medical Research Institute to Develop a Monoclonal Antibody for the Prevention of Malaria

Atreca Inc a clinicalstage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response today announced that it has entered into a licensing agreement with the Bill Melinda Gates Medical Resea...

21

Oct 2021

Specialised Therapeutics Enters into a New Supply and Distribution Agreement with Incyte to Launch Two New Cancer Therapies

Independent pharmaceutical company Specialised Therapeutics Asia Pte Ltd ST will partner with Incyte Biosciences International Srl the Swissbased affiliate of Incyte to launch and distribute two new medicines for its haematology and oncology portfolios tafasitamab sold as Monjuvi in the United State...

20

Oct 2021

Turkish Cargo Has Been Carrying Cancer Medicine for 25 Years

Possessing the worlds strongest cargo flight network Turkish Cargo contributes its strength to Turkeys medical exports Flag carrier air cargo brand has been carrying Turkeys medicine and medical products to over countries in five continents for over years In the nuclear medicine sector Turkish Car...

19

Oct 2021

Boehringer Ingelheim and Partners to Accelerate Development of First-In-Class Gene Therapy for Patients with Cystic Fibrosis

Boehringer Ingelheim IP Group the UK Cystic Fibrosis Gene Therapy Consortium GTC consisting of researchers from Imperial College London and the Universities of Oxford and Edinburgh and Oxford Biomedica OXB announced today that Boehringer Ingelheim has exercised its options on intellectual property a...

EventsRead more...

25 - 27

Oct 2021

World Obesity and Weight Management Congress 2021

Holiday Inn Orlando

25 - 27

Oct 2021

International Vaccines Congress 2021

Orlando

28 - 29

Oct 2021

Pharmacovigilance Drug Safety

Dubai

29 - 01

Oct 2021

Human Health Summit 2021

Online

01 - 02

Nov 2021

Pharmacology and Drug Discovery 2021

New York

03 - 07

Nov 2021

Napa Primary Care Conference 2021

Napa Valley Marriot Resort and Spa

06 - 08

Nov 2021

Biotechnology and Bioengineering (ECBB 2021)

Rome

10 - 14

Nov 2021

41st Congress of the SIU

Dubai

Saving Money, Saving Time In Pharma Operations
Thermo Fisher Scientific || Revolutionize your mAb manufacturing
Kerry || Webinar || Coatings Change Control Webinar || Recording-Webinar
Rousselot || X-Pure® GelMA
Meco - 90 years
Medical Fair Thailand 2022
Emirates Surgical Pathology Conference 2021

TOP ARTICLES

  • 3

    Metabolic Stability

     The liability of a drug substance to the metabolism is referred to as metabolic stability The liver uses CYPme...

KNOWLEDGE BANK

  • Interviews

    Porton Pharma Solutions and Codexis Launch Global Partnership

    PARTNERSHIP

    Codexis Inc and Porton Pharma Solutions Ltd announce a strategic collaboration to deploy Codexis worldleading biocatalyst technology within Portons global custom intermediate and active pharmaceutical ingredients API development and manufacturing business The partnership will accelerate the creation and commercialization of new lowcost sustainable manufacturing processes exploiting the benefits of...

Advisory Board

Stella Stergiopoulos

Stella
Sanjoy Ray

Sanjoy Ray
Rustom Mody

Rustom
Phil Kaminsky

Phil
Neil J Campbell

Neil J
Laurence Flint

Laurence
Kenneth I Kaitin

Kenneth I
Georg C Terstappen

Georg C
Frank A Jaeger

Frank A
Douglas Meyer

Douglas
Christopher-Paul Milne

Christopher-
Alan S Louie

Alan S Louie

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...